Donald Metcalf: the Father of Modern Hematology Jerry M

Total Page:16

File Type:pdf, Size:1020Kb

Donald Metcalf: the Father of Modern Hematology Jerry M RETROSPECTIVE Donald Metcalf: The father of modern hematology Jerry M. Adams1 and Suzanne Cory Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia On December 15, 2014, the hematology and founded each colony and for the previously leukemia research communities lost one of unknown extracellular cytokines required for their greatest leaders to pancreatic cancer. their survival and proliferation, which Don Through a remarkable 60-year research ca- termed “colony-stimulating factors” (CSFs). reer, Donald Metcalf led the discovery and Over time, Don’s team and others devised characterization of the regulators of blood similarclonalassaysfortheprogenitorsof cell production. The legacy of his work is not other white blood cell types, eventually reveal- only that blood cells have become the best- ing the complete genealogical “tree” from the understood complex biological system, but multipotential blood stem cell to the diverse also that the clinical applications of its reg- mature cell types. Furthermore, Don’sper- ulators have already benefited over 20 million ceptive analysis revealed that their leukemic cancer patients. counterparts had acquired self-renewal hall- Metcalf—Dontoallwhoknewhim—was marks of stem cells while losing features of born in 1929 in Mittagong, a small Australian terminal differentiation. The insights gained countrytowninNewSouthWales.Hisfirst on the multifaceted blood cell system made it scientific work, on ectromelia virus, came du- a paradigm for the normal and neoplastic de- ring medical training at the University of Syd- velopment of many other tissue types. ney. In 1954, Don moved to Melbourne’s From the outset, Don had the bold vision Walter and Eliza Hall Institute of Medical that if the CSFs could be purified in sufficient Research (WEHI), which became his perma- amounts, they could become new medicines Donald Metcalf. Image courtesy of The Walter nent scientific home. Throughout his career, for augmenting blood cell production in pa- and Eliza Hall Institute of Medical Research. Don was supported by a unique fellowship tients receiving cancer chemotherapy or bone from the Cancer Council of Victoria. marrow transplants. In the 1970s, however, Don first worked on vaccinia virus this seemed a pipe dream. Early purification and Nick Gough in leading roles, to clone with the institute’s director, the eminent efforts had revealed that these proteins were GM-CSF cDNA (3). Large-scale production of the CSFs from virologist and later Nobel Prize-winning made in only trace amounts and that gran- ’ immunologist, Sir Macfarlane Burnet. Unfor- ulocyte and macrophage development was cloned genes finally permitted tests of Don s tunately, Don’s intent to pursue cancer re- stimulated by at least four different factors, vision for medical application, with clinical search, which was further whetted by a now denoted granulocyte (G)-CSF, macro- colleagues, such as George Morstyn, Glenn two-year postdoctoral fellowship at Harvard, phage (M)-CSF, granulocyte-macrophage (GM)- Begley, and Richard Fox, assuming vital roles. rankled the autocratic Burnet, who regarded CSF, and multi-CSF (IL-3). Excitingly, just as Don had predicted, clinical cancer as “an inevitable disease” and, there- Recognizing that achieving his goal would trials showed that G- or GM-CSF treatment fore, anyone who chose to study it as “either require intense application of biochemistry reduced the dangerous drop in white blood afoolorarogue.” Consequently, Don was and molecular biology, as well as cell and cells in cancer patients following chemother- “banished” for years to the smelly, allergy- animal biology, Don showed great leadership apy or radiotherapy (4). In an unexpected inducing, animal house, from which he was in inspiring younger colleagues with those bonus, Don and colleagues found that these only rescued when the directorship passed skills to share his vision. What Don’s autobi- CSFs mobilized hematopoietic stem cells to Gus Nossal, who greatly admired Don’s ography (2) termed the “dogged pursuit” of from the bone marrow into the blood (5). work, as did the subsequent WEHI Direc- the CSFs proved arduous, requiring up to The ease of harvesting the mobilized stem tors (Suzanne Cory and Doug Hilton). a million-fold enrichment and yielding only cells from blood and their rapid ability to In 1966 came the illuminating discovery microgram amounts. Key colleagues in replenish the blood cell system have trans- underpinning all of Don’ssubsequent this Herculean endeavor included Richard formed medical practice: their injection has research: he and Ray Bradley found that Stanley, Tony Burgess, and Nic Nicola. Fi- rendered bone marrow transplantation largely granulocytes and macrophages, essential nally, a decade of effort yielded the amino obsolete and greatly extended the range of components of the body’s immune system, acid sequence of GM-CSF fragments. In could be grown as colonies in soft agar (1). 1984, using the emerging genetic engineer- Author contributions: J.M.A. and S.C. wrote the paper. This seminal finding immediately provided ing technology, this information enabled 1To whom correspondence should be addressed. Email: adams@ an assay for the single progenitor cell that the team, which now included Ashley Dunn wehi.edu.au. 2628–2629 | PNAS | March 3, 2015 | vol. 112 | no. 9 www.pnas.org/cgi/doi/10.1073/pnas.1500346112 Downloaded by guest on October 1, 2021 cancer patients able to receive intensive of his life held at WEHI only three months data.” Don always resisted speculation and RETROSPECTIVE chemotherapy. before his death: reflecting their universal ad- derided those who built houses of cards from Don Metcalf ’s singular achievements have miration and respect for Don, almost the en- minimal data as “strutters” and “snake-oil “ been recognized by numerous major prizes tire WEHI staff formed a cheering Guard of salesmen.” ” and honors, including the Robert Koch Prize Honor to escort him into the institute, weak- Don himself should have the final words (1988), the Sloan Prize of the General Motors ened in body but never in mind or spirit. on his lifelong motivation (7): “Ican’twaitto Cancer Research Foundation (1989), the What characteristics allowed Donald get to work. ...It’s like Christmas, isn’tit? Albert Lasker Award for Clinical Medical Re- Metcalf to publish 739 scientific papers plus Opening the incubator door and getting out search (1993), the Gairdner Foundation In- nine books and remain at the apex of hema- tray loads of cultures and saying, ‘Well, ternational Award and US National Academy tology for over 50 years? All attest to Don’s what’s happened? ... Iwonderwhathap- of Sciences Kovalenko Medal (1994), the focus, tenacity, integrity, and diligence, per- ’ ... ’ Royal Medal of the Royal Society of London haps ingrained by his Scottish Presbyterian pened. [If it] hasn t worked again, well, ... ’ ” (1995), Harvard University’s Warren Alpert upbringing. As Nossal has noted (6), another day tomorrow, we ll try again. In Foundation Prize (1997), the Chiron Interna- “Don’s 10-hour days at the microscope keeping with that spirit, when his cancer pro- tional Award (1999), the Donnall Thomas (bad back notwithstanding) have become gressed, Don had his favorite microscope Prize of the American Society of Hematology, legendary....But perhaps the biggest single moved into his home and continued working the inaugural Salk Institute Medal for Re- factor was [his] devotion to the primary until a few weeks before his death. search Excellence (2005), and the Lifetime Achievement Award of the American Asso- ciation for Cancer Research and Grand Hamdan International Award (2007). Don 1 Bradley TR, Metcalf D (1966) The growth of mouse 5 Dührsen U, et al. (1988) Effects of recombinant human bone marrow cells in vitro. Aust J Exp Biol Med Sci 44(3): granulocyte colony-stimulating factor on hematopoietic progenitor was also elected to numerous learned societies, 287–299. cells in cancer patients. Blood 72(6):2074–2081. including the Australian Academy of Science, 2 Metcalf D (2000) Summon up the Blood: In Dogged Pursuit of 6 Nossal G (2009) in Celebrating the achievements of Professor Don the Blood Cell Regulators (AlphaMed Press, Dayton, OH). Metcalf on his 80th birthday. Available at www. the US National Academy of Sciences, the 3 Gough NM, et al. (1984) Molecular cloning of cDNA discoveriesneeddollars.org/uploads/pdf/donmetcalf.pdf. Accessed Royal Society, and the Academy of the Amer- encoding a murine haematopoietic growth regulator, granulocyte- January 22, 2015. ican Society for Cancer Research. Despite this macrophage colony stimulating factor. Nature 309(5971):763–767. 7 Metcalf D (2009) in Celebrating the achievements of Professor 4 Morstyn G, et al. (1988) Effect of granulocyte colony stimulating Don Metcalf on his 80th birthday. Available at www. wealth of international acclaim, we suspect factor on neutropenia induced by cytotoxic chemotherapy. Lancet discoveriesneeddollars.org/uploads/pdf/donmetcalf.pdf. Accessed that Don was equally moved by the celebration 1(8587):667–672. January 22, 2015. Adams and Cory PNAS | March 3, 2015 | vol. 112 | no. 9 | 2629 Downloaded by guest on October 1, 2021.
Recommended publications
  • To Professor Suzanne Cory AC
    Citation for the Award of the Doctor of Laws (Honoris Causa) to Professor Suzanne Cory AC When Suzanne Cory graduated from the Science Faculty at the University of Melbourne molecular biology was in its infancy. In her enthusiasm for this new science she pursued a PhD in Cambridge at the Medical Research Council’s famed Laboratory of Molecular Biology. Immersed in a culture of discovery, her pioneering PhD studies determined the sequence of a transfer RNA, utilising new technology developed by Fred Sanger, one of the three Nobel Laureates in the institute. After three years’ post‐doctoral work at the University of Geneva, Suzanne Cory returned to Australia with her husband, Jerry Adams, to the Walter and Eliza Hall Institute of Medical Research where they helped to introduce gene‐cloning technology to Australia. Since then, her long association with the Institute, including thirteen years as Director, and with the University of Melbourne, has been instrumental in building the international reputation of both institutions and the strength of the Parkville biomedical research network. Suzanne Cory has made major contributions to advancing the science of immunology, cancer and genetics, in a lifelong dynamic research partnership with Adams. Her work is published widely and cited frequently. The positions held by the many PhD candidates and Post‐Doctoral Fellows she has supervised demonstrate her intergenerational influence in developing scientific leaders for the future. The list of accolades and awards Suzanne Cory has received in recognition of her contributions to science is long and distinguished. She was elected a Fellow of the Australian Academy of Science in 1986 and since has been elected to numerous sister organisations across the globe.
    [Show full text]
  • Conference Participants
    Conference Participants Frederic G. Barr, M.D., Ph.D. David Livingston, M.D. Department of Pathology and Laboratory Emil Frei Professor of Medicine and Genetics Medicine Dana-Farber Cancer Institute University of Pennsylvania School of Medicine Harvard Medical School Philadelphia, Pennsylvania Boston, Massachusetts Anton Berns, Ph.D. Ahmed Mansouri, Ph.D. Division of Molecular Genetics Department of Molecular and Cellular Biology The Netherlands Cancer Institute Max Planck Institute of Biophysical Chemistry Amsterdam, The Netherlands G6ettingen, Germany Mina J. Bissell, Ph.D. Director, Life Sciences Division Sharon B. Murphy, M.D. Lawrence Berkeley National Laboratory Chief', Division of Hematology/Oncology Berkeley, California Children's Memorial Hospital Professor of Pediatrics Meinrad Busslinger, Ph.D. Northwestern University Medical School Senior Scientist Chicago, Illinois Research Institute of Molecular Pathology University of Vienna Stuart H. Orkiu, M.D. Vienna, Austria Leland Fikes Professor of Pediatric Medicine Mario R. Capecchi, Ph.D. Harvard Medical School Eccles Institute of Human Genetics Boston, Massachusetts University of Utah Bruce A. J. Ponder, Ph.D. Salt Lake City, Utah CRC Professor of Ontology Lewis A. Chodosh, M.D., Ph.D. University of Cambridge Assistant Professor Cambridge, England Department of Molecular and Cellular United Kingdom Engineering Division of Endocrinology, Diabetes and Terry H. Rabbits, Ph.D., F.R.S. Metabolism Medical Research Council Laboratory of University of Pennsylvania School of Medicine Medical Biology Philadelphia, Pennsylvania Joint Head, Division of Protein and Nucleic Acid Chemistry Suzanne Cory, Ph.D., F.A.A., F.R.S. Head, Subdivision of Biology Professor of Medical Biology Cambridge, England The Walter and Eliza Hall Institute of Medical United Kingdom Research Melbourne, Australia Giinter Schiitz, M.D.
    [Show full text]
  • 'What's a Nice Girl Like You Doing with a Nobel Prize?' Elizabeth Blackburn, 'Australia's' First Woman Nobel Laureat
    ‘What’s a Nice Girl like you Doing with a Nobel Prize?’ Elizabeth Blackburn, ‘Australia’s’ First Woman Nobel Laureate and Women’s Scientific Leadership Jane Carey Centre for Women’s Studies and Gender Research/Monash Indigenous Centre Monash University, Clayton VIC 3800 [email protected] Abstract: In 2009 Elizabeth Blackburn (along with two of her American colleagues) won the Nobel Prize for Physiology or Medicine, confirming her position as a global scientific leader. She was immediately celebrated as Australia’s first woman Nobel laureate. However, although 2009 was a ‘bumper’ year for women Nobel laureates, with five winners in total, the media coverage soon became highly negative and discouraging. Much discussion focused not on Blackburn’s scientific work but on her gender – the difficulties it was assumed she must have faced individually as a woman scientist, and her wider leadership role in encouraging and supporting other women to overcome these obstacles. In this chapter I suggest the continuing highly negative ways the possibilities for women’s participation and leadership in science are discussed are counterproductive. Journalistic, policy and scholarly discussions of the ‘problem’ of women in science misconstrue the extent of women’s participation in the field and the nature of their experiences. In all these spheres, science continues to be understood and represented as an unhappy place for women to be. This misrepresentation, I argue, undercuts the leadership roles women scientists are seeking. Keywords: Elizabeth Blackburn, women scientists, Australian science, gender and science, Nobel Prize On 5 October 2009 molecular biologist Elizabeth Blackburn received a phone call from Geneva with the news that she, along with her American colleagues Carol Greider and Jack W.
    [Show full text]
  • 2020 Annual Report
    2020 Annual Report Make this cover come alive with augmented reality. Details on inside back cover. Contents The Walter and Eliza Hall Institute About WEHI 1 of Medical Research President’s report 2 Parkville campus 1G Royal Parade Director’s report 3 Parkville Victoria 3052 Australia Telephone: +61 3 9345 2555 WEHI’s new brand launched 4 Bundoora campus 4 Research Avenue Our supporters 10 La Trobe R&D Park Bundoora Victoria 3086 Australia Exceptional science and people 13 Telephone: +61 3 9345 2200 www.wehi.edu.au 2020 graduates 38 WEHIresearch Patents granted in 2020 40 WEHI_research WEHI_research WEHImovies A remarkable place 41 Walter and Eliza Hall Institute Operational overview 42 ABN 12 004 251 423 © The Walter and Eliza Hall Institute Expanding connections with our alumni 45 of Medical Research 2021 Diversity and inclusion 46 Produced by the WEHI’s Communications and Marketing department Working towards reconciliation 48 Director Organisation and governance 49 Douglas J Hilton AO BSc Mon BSc(Hons) PhD Melb FAA FTSE FAHMS WEHI Board 50 Deputy Director, Scientific Strategy WEHI organisation 52 Alan Cowman AC BSc(Hons) Griffith PhD Melb FAA FRS FASM FASP Members of WEHI 54 Chief Operating Officer WEHI supporters 56 Carolyn MacDonald BArts (Journalism) RMIT 2020 Board Subcommittees 58 Chief Financial Officer 2020 Financial Statements 59 Joel Chibert BCom Melb GradDipCA FAICD Financial statements contents 60 Company Secretary Mark Licciardo Statistical summary 94 BBus(Acc) GradDip CSP FGIA FCIS FAICD The year at a glance 98 Honorary
    [Show full text]
  • SPHPM Annual Report 2008 the School of Public Health and Preventive Medicine Is a Leading Centre for Clinical and Population Health Research
    SPHPM Annual Report 2008 The School of Public Health and Preventive Medicine is a leading centre for clinical and population health research. Cover image: PhD student, Lavinia Tran. Contents Overview. 2 2008 SPHPM highlights . 4 New centres, registries and collaborations. 5 Research and education summary . 6 2008 SPHPM organisational structure . 7 Research governance . 8 Awards, prizes and fellowships . 9 Registries . 11 Visitors . 14 Seminars. 17 Short courses . 19 Teaching . 21 SPHPM Doctoral program . 26 Funding sources . 35 Publications . 44 Staff . 63 School of Public Health and Preventive Medicine | 1 Overview The School of Public Health and Preventive Medicine (SPHPM) within the Monash University Faculty of Medicine, Nursing and Health Sciences, is one of the largest Schools of Public Health in the Asia Pacific Region, providing extensive opportunities for education, collaborative research and community engagement. SPHPM Executive Group. Standing, left to right: Professor Peter Cameron, Associate Professor Max de Courten, Professor Brian Oldenburg, Associate Professor Damien Jolley, Professor John McNeil, Professor Helen Keleher, Professor Bob Atkins, Professor Joan Ozanne-Smith, Dr Rob hall, Dr Elizabeth Douglas and Professor Andrew Tonkin. Seated, left to right: Associate Professor Chris Reid, Professor Flavia Cicuttini, Ms Lynda Caldwell, Dr Chris Stevenson, Professor Just Stoelwinder, Professor Robert Burton and Dr Belinda Gabbe. Absent: Dr Helena Teede, Professor Paul O’Brien, Professor Paul Myles, Professor Steven Cordner, Professor Andrew Forbes, Associate Professor Wendy Brown, Dr Anna Peeters, Associate Professor Bebe Loff, Professor Brian Priestly, Dr David Goddard, Professor Henry Krum, Associate Professor Karin Leder, Professor Malcolm Sim, Dr Martha Sinclair, Associate Professor Rory Wolfe, Professor Rachelle Buchbinder, Professor Michael Abramson and Ms Martine Radegonde.
    [Show full text]
  • Suzanne Cory’S Passion in Every Sense
    NEWS Biomedical research has been Suzanne Cory’s passion in every sense. She has worked to decode the genetic mysteries of the immune system and cancer, has rallied her country to invest in its scientific future, and is married to a fellow scientist from her post-doctoral years. Nature Medicine talked to the Director of the Walter and Eliza Hall Institute in Melbourne to find out why her love affair with science hasn’t waned in intensity over four decades. Suzanne Cory Reinvigorated from trekking in one of New stamp on Cory’s life: “It was an environ- vival in tumorigenesis. Together with Zealand’s most challenging mountain ment steeped in scientific passion and rigor Adams and a PhD student, David Vaux, ranges during a rare break from work, Cory —four Nobel laureates and ambitious post- Cory discovered that BCL-2, the oncogene was brimming with enthusiasm. docs from all around the world, hungry for activated by chromosome translocation in Uppermost is excitement about her in- success. It was there that I realized that human follicular lymphoma, had a very volvement in a consortium bidding for the there are no half measures in science — the different mode of action than all previ- Federal Government’s Biotechnology commitment has to be all or nothing.” ously characterized oncogenes. Rather Center of Excellence—the winner will be And it was there that she met fellow scien- than stimulating cell proliferation, BCL-2 announced later this year. Cory and her tist Jerry Adams. They married and em- promotes cell survival. “Nobody then colleagues have the bold vision of estab- barked on a research career together, dreamed that simply stopping a cell from lishing a Therapeutics Development which began with post-docs in Geneva.
    [Show full text]
  • High Achiever Data 2019 Student List
    High Achiever Data 2019 Student List A AALBERS Andreas Julian Jarvis Haileybury College, Keysborough Music Investigation 40 A ALMAJEED Ameer VSL Distance Education, Thornbury Languages:Arabic 42 AARON Lottie Rosina Williamstown High School Food Studies 44 AARONS Liam Cameron Braemar College, Woodend Chemistry 42 Mathematical Methods 40 Physics 40 AARONS Raife Alexevich Woodleigh School, Langwarrin South Further Mathematics 41 ABAYAWARDANA Naomi Suzanne Cory High School, Werribee Psychology 42 ABBAS Salma Thornbury High School Health and Human Development 46 ABBAS Shiraz Adil Mohamed MacRobertson Girls High School, Melbourne Economics 43 ABBENANTE Christopher Francis St Bernard's College, Essendon Physics 41 ABBOTT Aaron Glen Waverley Secondary College Computing: Software Development 40 ABBOTT Charlotte Leslie Camberwell Anglican Girls Grammar School, Canterbury History Revolutions 43 Legal Studies 44 ABBOTT Jamilla Jean Jaffers Eltham High School English 40 Health and Human Development 43 Philosophy 40 Psychology 47 ABBS Caitlin Sylenna Ballarat Clarendon College Further Mathematics 47 Health and Human Development 45 ABDALLAH Laura Anne Genazzano F.C.J. College, Kew English 43 Languages:Italian 40 ABDELLAH Sohaib Sirius College - Meadow Fair Campus, Broadmeadows Further Mathematics 43 ABDI Zina Keilor Downs College Biology 40 ABDULLAH Afra Sirius College - Eastmeadows Campus, Broadmeadows English 46 Psychology 41 ABDULLAH Hasan Ali VSL - University/Brunswick/Collingwood, Parkville Languages:Arabic 42 ABDULNOUR Juline Nicola Penleigh and
    [Show full text]
  • 2019 Annual Report of the Royal Society of Victoria
    PATRON: The Hon Linda Dessau AC PRESIDENT: Mr David Zerman Governor of Victoria 2019 Annual Report THE ROYAL SOCIETY OF VICTORIA INCORPORATED ABN 62 145 872 663 ANNUAL REPORT FOR THE YEAR ENDING 31st DECEMBER 2019 Council has the honour to present its report to Members upon the activities of the Society during its 165th year of operation. PATRON The Hon Linda Dessau AC Governor of Victoria COUNCIL OFFICE BEARERS President Mr D. Zerman, MPH, FFIA, CFRM, FAIM Vice-President Mrs N. H. Williams, BSc, DipEd, MSc, FRACI Immediate Past President Dr W. D. Birch AM, BSc (Hons), PhD Honorary Secretary Dr P. G. Baines BA (Hons), BSc, PhD Honorary Treasurer Mr A. Davison, BSc, BComp (Hons) MEMBERS Dr S. Frentz, BSc (Hons), PhD Dr V. Perunicic, BSc (Hons), MSc, PhD A/Prof. R. Day, BSc (Hons), PhD A/Prof. G. Smith, BPS, GradDip, MEH, PhD Dr K. Orrman-Rossiter, BAppPhys, MAppSci, PostgradDip, PhD Dr C. de Burgh-Day, BSc, MSc, PhD Ms P. Borger, BSc (Hons), DipEd, MEd Mr R. Gell AM, BEng Prof. D. Walker, BSc, PhD, DSc Dr J. Boyce, MGeosci (Hons1), PhD RETURNING OFFICER Em. Prof. J. W. Warren, MA, PhD Dr. D. A. McCann, DipAppChem, DipEd, GradDipLib, MEnvSc, PhD (Deputy) CHIEF EXECUTIVE OFFICER Mr M. Flattley, BA, GradCert, GradCertDes TRUSTEES Dr D. M. Churchill, ,BSc MA, IPPA, PhD Dr A. S. Finkel AO, PhD, FAA, FTSE Prof. L. Selwood AO, MSc, PhD Em. Prof. J. W. Warren, MA, PhD Cover: NASA Scientist Dr Darlene Lim presenting in Victoria’s Legislative Council Chamber on 10th August, 2019 as a part of Extrasensory, the Society’s major event at Parliament House for National Science Week RSV Annual Report for Year Ending 31st December 2019 Page 2 of 61 FELLOWS OF THE ROYAL SOCIETY OF VICTORIA 1995 David H.
    [Show full text]
  • LONG-TERM MEMBERS 25+ Years of Membership
    LONG-TERM MEMBERS 25+ Years of Membership Stuart A. Aaronson, MD Stephen P. Ackland, MBBS Carol Aghajanian, MD Steven A. Akman, MD Icahn School of Medicine at Mount Sinai University of Newcastle Memorial Sloan Kettering Cancer Center Roper St. Francis Healthcare United States Australia United States United States Active Member Active Member Active Member Active Member 38 Years of Membership 33 Years of Membership 27 Years of Membership 35 Years of Membership Cory Abate-Shen, PhD Edward M. Acton, PhD Irina U. Agoulnik, PhD Emmanuel T. Akporiaye, PhD Columbia University Irving Medical United States Florida International University Verana Therapeutics Center Emeritus Member United States United States United States 42 Years of Membership Active Member Emeritus Member Active Member 25 Years of Membership 31 Years of Membership 26 Years of Membership David J. Adams, PhD Duke University Medical Center Imran Ahmad, PhD Ala-Eddin Al Moustafa, PhD James L. Abbruzzese, MD United States Northwestern Medicine McGill University Duke University Emeritus Member United States Canada United States 32 Years of Membership Active Member Active Member Active Member 25 Years of Membership 26 Years of Membership 32 Years of Membership Gregory P. Adams, PhD Elucida Oncology Nihal Ahmad, PhD Abdul Al Saadi, PhD Ehtesham A. Abdi, MBBS United States Univ. of Wisconsin Madison Sch. of Med. William Beaumont Hospital The Tweed Hospital Active Member & Public Health United States Australia 29 Years of Membership United States Emeritus Member Emeritus Member Active Member 52 Years of Membership 33 Years of Membership Lucile L. Adams-Campbell, PhD 25 Years of Membership Georgetown Lombardi Comprehensive Suresh K.
    [Show full text]
  • Burnet Booklet.Indd
    Second and Revised Edition, 2007 Introduction Professor Suzanne Cory, Director of The Walter and Eliza Hall Institute of Medical Research Frank Macfarlane Burnet’s theory of clonal selection Hall Institute of Medical Research an international focus on profoundly and forever changed the way that scientists all immunological research and application. Today, immunology over the world understand the working of immunity. In remains one of Australia’s strongest sciences. One third doing so, he brought to Victoria and The Walter and Eliza of the nation’s immunologists work in Victoria and four Australians of the Year have been immunologists. By comparison with today’s overwhelmingly collaborative nature of research and authorship, the circumstances of the creation of Burnet’s paper in 1957 appear quite amazing. While today we are accustomed to more than a dozen researchers acknowledged as contributors to a paper and papers likely to have been drafted many times over many months, by contrast Burnet’s paper was precisely that – Burnet’s alone; and he wrote the paper over the course of a weekend at home. Equally astonishing is the fact that such a revolutionary theory, which caused a seismic shift in thinking, was encapsulated in only a few pages of text. Part of the measure of the greatness of Burnet’s achievement is that today’s immunologists tell us that Burnet’s theories so thoroughly infuse their thinking that it seems impossible to imagine that the world of immunology could ever have been any other way. This universal infusion of Burnet’s theories marks him as one of Australia’s greatest ever scientists.
    [Show full text]
  • Strategic Review of Health and Medical Research Final Report
    Strategic Review of Health and Medical Research Final Report | February 2013 B ette r H ea lth T h ro u g h R e s e a r c h Cover Art. The images on the front cover refl ect the connection between health and medical research, improved healthcare and economic and social outcomes: 1. Clinician researchers are often the starting point for health and medical research hypotheses. 2. Biomedical research, such as research into brain neurons, provides the foundation knowledge that leads to new discoveries and clinical interventions. 3. CSL Limited is a global leader in blood products, and uses research discoveries to create national wealth and deliver improved healthcare (Image courtesy of CSL Limited). 4. Health professionals deliver improved services to consumers into evidence- based healthcare. 5. The Australian community benefi ts from increased longevity and good health. 6. Health and medical research drives benefi ts for all Australians in terms of better heath and increased prosperity. Strategic Review of Health and Medical Research in Australia – Better Health Through Research ISBN: 978-0-9872039-6-0 © Commonwealth of Australia 2013 This work is copyright. You may download, display, print and reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without fi rst being given the specifi c written permission from the Commonwealth to do so.
    [Show full text]
  • Annual Report 2014
    SCHOOL OF CHEMISTRY ANNUAL REPORT 2014 SCHOOL OF CHEMISTRY CONTACT THE SCHOOL Annual Report 2014 +61 3 8344 6567 Chemistry Building SPONSORS The University of Melbourne Agilent Technologies Victoria 3010 Australia Australian Nuclear Science and Technology Organisation www.chemistry.unimelb.edu.au Australian Research Council Australian Synchrotron Compiled by Jenny Long BHP Billiton [email protected] Chemistry Education Association Inc Crocodile Gold Corp (Stawell Gold Mines) Dairy Innovation Australia Ltd Dulux Australia Huntsman Corporation Australia Pty Ltd FRONT COVER IMAGE Melbourne Water From work by Lachlan McInnes, Gojko Buncic, Brett Paterson National Health and Medical Research Council and Paul Donnelly. Positron emission tomography (PET) can be used for the diagnosis and characterisation of breast cancer. The PerkinElmer figure above shows a PET image of a positron-emitting copper cage Peter MacCallum Cancer Institute amine complex tethered to an antibody (trastuzumab) selectively Victorian Government Science Technology Innovation (STI) binding to a breast tumour xenograft in a mouse model. 2 School of Chemistry Annual Report 2014 CONTENTS INTRODUCTION FROM THE HEAD OF SCHOOL 4 OUR PEOPLE 5 NEWS 7 SOCIETIES 15 PRIZES AND AWARDS 16 CHEMISTRY OUTREACH PROGRAM 17 SUBJECTS 18 KEY TEACHING AND LEARNING STATISTICS 19 RESEARCH HIGHER DEGREE STUDENT COMPLETIONS 20 RESEARCH 22 CONFERENCES 24 INORGANIC AND ANALYTICAL SEMINARS 28 ORGANIC SEMINARS 29 PHYSICAL SEMINARS 30 PUBLICATIONS 2014 31 www.chemistry.unimelb.edu.au 3 INTRODUCTION FROM THE HEAD OF SCHOOL The year 2014 was the International Year of Crystallography which the School of Chemistry celebrated by a holding a series of public lectures and with an exhibition, ‘Reflections: tales from within the crystal’, which featured specimens, models and instrumentation from our historical collection.
    [Show full text]